Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Lumify™ (brimonidine) – New over-the-counter drug approval
December 22, 2017 – Bausch and Lomb announced the FDA approval of Lumify (brimonidine) 0.025% ophthalmic solution, to relieve redness of the eye due to minor eye irritations.
